Iktos
Iktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate, reducing timelines to under 24 months.
$16M Series A ·
Source: startupintros.com
Funding history ↓Signals
Iktos | 1909 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $16M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
- YGYann Gaston-Mathé Co-Founder & CEOsource: iktos.ai
Companies like Iktos
DDenovo SciencesPPeptone$40M Series A · Jun 2022
EExcelsior Sciences$95M Series A · Dec 2025
IInductive Bio$25M Series A · May 2025
AAlzheon$100M Series B+ · Apr 2022
MMolecular GateSeed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/iktos (get a free API key).